shutterstock_1851003727_michael_vi

Michael Vi / Shutterstock.com

24 October 2023Big PharmaMarisa Woutersen

ITC investigates online pharmacies after Eli Lilly complaint

International Trade Commission is to investigate 11 online pharmacies after Eli Lilly files trademark infringement complaint | The company accuses pharmacies of selling “low-grade” versions of its Mounjaro diabetes medicine.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Eli Lilly walks away from $176.5m damages after judge overturns Teva win

28 September 2023 Teva’s patents protecting migraine drug ruled invalid | Lilly’s motion for a new trial denied | ‘The court does not reach this decision nor overturn a jury verdict lightly’ says Judge Alison Burroughs.

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

27 March 2019 The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

More on this story

Eli Lilly walks away from $176.5m damages after judge overturns Teva win

28 September 2023 Teva’s patents protecting migraine drug ruled invalid | Lilly’s motion for a new trial denied | ‘The court does not reach this decision nor overturn a jury verdict lightly’ says Judge Alison Burroughs.

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

27 March 2019 The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

More on this story

Eli Lilly walks away from $176.5m damages after judge overturns Teva win

28 September 2023 Teva’s patents protecting migraine drug ruled invalid | Lilly’s motion for a new trial denied | ‘The court does not reach this decision nor overturn a jury verdict lightly’ says Judge Alison Burroughs.

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

27 March 2019 The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB